KISS1 and obesity disorder: The work represents initial evidence that kisspeptin-10 simultaneously modulates gut hormone-producing cell populations and protects pancreatic islet architecture in female HFD-fed mice, supporting a potential therapeutic role for kisspeptin in obesity-related insulin resistance and fertility disorders.